Ligand validation:8IRF

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRF_HTG_B_624	77%	43%	0.102	0.94	1.16	1.09	2	1	0	0	100%	1
8IRF_HTG_b_625	67%	39%	0.113	0.923	1	1.45	2	4	0	0	100%	1
8IRF_HTG_o_301	45%	32%	0.156	0.888	1.11	1.69	2	5	0	0	100%	1
8IRF_HTG_b_622	32%	23%	0.18	0.852	1.21	2.09	3	7	0	0	100%	1
8IRF_HTG_B_622	19%	42%	0.243	0.836	0.83	1.47	1	1	0	0	100%	1
8IRF_HTG_c_521	12%	38%	0.273	0.803	0.93	1.54	1	1	0	0	100%	1
8IRF_HTG_d_410	10%	38%	0.295	0.825	0.99	1.49	1	1	0	0	84%	0.8421
8IRF_HTG_C_522	6%	43%	0.331	0.776	0.86	1.39	1	2	0	0	100%	1
8IRF_HTG_D_410	6%	37%	0.278	0.732	0.96	1.59	1	1	0	0	84%	0.8421
8IRF_HTG_V_202	3%	57%	0.48	0.918	0.36	1.24	-	1	0	0	58%	0.5789
8IRF_HTG_b_623	1%	28%	0.493	0.716	1.07	1.93	1	3	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.